Skip to main content
. 2021 Jun 1;12:648691. doi: 10.3389/fpsyg.2021.648691

TABLE 2.

Sensitivity analyses for MADRS score decreased from baseline to 2–4 h.

Model Excluded study Sample WMD (95%CI) P value Heterogeneity P value for heterogeneity
Model 1 None 198 6.16 (4.44,7.88) 0.00 64.70% 0.04
Model 2 Daly 2018 (84 mg) 154 5.47 (3.87,7.08) 0.00 38.00% 0.20
Model 3 Daly 2018 (56 mg) 154 6.99 (5.53,8.45) 0.00 29.00% 0.24
Model 4 Daly 2018 (28 mg) 154 5.84 (3.24,8.45) 0.00 76.00% 0.02
Model 5 Canuso 2018 132 6.41 (4.50,8.31) 0.00 74.00% 0.02

Model represented inclusion with the studies. Mode 1: Canuso 2018, Daly 2018 (28 mg), Daly 2018 (56 mg), and Daly 2018 (84 mg) included. Mode 2: Canuso 2018, Daly 2018 (28 mg), and Daly 2018 (56 mg) included. Mode 3: Canuso 2018, Daly 2018 (28 mg), and Daly 2018 (84 mg) included. Mode 4: Canuso 2018, Daly 2018 (56 mg), and Daly 2018 (84 mg) included. Mode 5: Daly 2018 (28 mg), Daly 2018 (56 mg), and Daly 2018 (84 mg) included.